[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:

  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.


This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 6,889
Sort by:

Acute ischemic stroke (AIS) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Acute ischemic stroke (AIS) Report Assessment Current Treatment Practices in Acute ischemic stroke (AIS) Unmet Needs in Acute ischemic stroke (AIS) Market Attractiveness Market Drivers and Barriers KEY ...

January 2022 200 pages

Acute ischemic stroke (AIS) - Epidemiology Forecast to 2032

US$ 3,950.00

... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acute ischemic stroke (AIS) Key assessments Patient Segmentation in Acute ischemic stroke (AIS) Acute ischemic stroke (AIS) Risk & Burden Factors driving growth in a specific Acute ischemic stroke (AIS) patient population

January 2022 60 pages

Acute Lymphoblastic Leukemia Epidemiology Forecast to 2032

US$ 3,950.00

... Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Lymphoblastic Leukemia (ALL) Key assessments Patient Segmentation in Acute Lymphoblastic Leukemia (ALL) Acute Lymphoblastic Leukemia (ALL) Risk & Burden Factors driving growth in a specific Acute Lymphoblastic Leukemia (ALL) patient population

January 2022 60 pages

Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Acute Myeloid Leukemia (AML) Report Assessment Current Treatment Practices in Acute Myeloid Leukemia (AML) Unmet Needs in Acute Myeloid Leukemia (AML) Market Attractiveness Market Drivers and Barriers KEY ...

January 2022 200 pages

Acute Myeloid Leukemia (AML) - Epidemiology Forecast to 2032

US$ 3,950.00

... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Myeloid Leukemia (AML) Key assessments Patient Segmentation in Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia (AML) Risk & Burden Factors driving growth in a specific Acute Myeloid Leukemia (AML) patient population

January 2022 60 pages

Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... Age-related Macular Degeneration (AMD) Market Opportunities Impact of upcoming Therapies in Age-related Macular Degeneration (AMD) Age-related Macular Degeneration (AMD) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Age ...

January 2022 200 pages

Age-related Macular Degeneration (AMD) - Epidemiology Forecast to 2032

US$ 3,950.00

... Year Forecast 7MM Coverage Total Cases in Age-related Macular Degeneration (AMD) Key assessments Patient Segmentation in Age-related Macular Degeneration (AMD) Age-related Macular Degeneration (AMD) Risk & Burden Factors driving growth in a specific Age-related Macular Degeneration (AMD) patient population

January 2022 60 pages

AIDS Related Kaposi's Sarcoma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition AIDS Related Kaposi's Sarcoma Report Assessment Current Treatment Practices in AIDS Related Kaposi's Sarcoma Unmet Needs in AIDS Related Kaposi's Sarcoma Market Attractiveness Market Drivers and Barriers ...

January 2022 200 pages

AIDS Related Kaposi's Sarcoma - Epidemiology Forecast to 2032

US$ 3,950.00

... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in AIDS Related Kaposi's Sarcoma Key assessments Patient Segmentation in AIDS Related Kaposi's Sarcoma AIDS Related Kaposi's Sarcoma Risk & Burden Factors driving growth in a specific AIDS Related Kaposi's Sarcoma patient population ...

January 2022 60 pages

Allergic Rhinitis - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Allergic Rhinitis Key assessments Patient Segmentation in Allergic Rhinitis Allergic Rhinitis Risk & Burden Factors driving growth in a specific Allergic Rhinitis patient population

January 2022 60 pages

Alzheimer's disease (AD) - Epidemiology Forecast to 2032

US$ 3,950.00

... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Alzheimer’s disease (AD) Key assessments Patient Segmentation in Alzheimer’s disease (AD) Alzheimer’s disease (AD) Risk & Burden Factors driving growth in a specific Alzheimer’s disease (AD) patient population

January 2022 60 pages

Amyotrophic lateral sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Amyotrophic lateral sclerosis (ALS) Report Assessment Current Treatment Practices in Amyotrophic lateral sclerosis (ALS) Unmet Needs in Amyotrophic lateral sclerosis (ALS) Market Attractiveness Market Drivers and Barriers KEY ...

January 2022 200 pages

Amyotrophic lateral sclerosis (ALS) - Epidemiology Forecast to 2032

US$ 3,950.00

... strengths 10 Year Forecast 7MM Coverage Total Cases in Amyotrophic lateral sclerosis (ALS) Key assessments Patient Segmentation in Amyotrophic lateral sclerosis (ALS) Amyotrophic lateral sclerosis (ALS) Risk & Burden Factors driving growth in a specific Amyotrophic lateral sclerosis (ALS) patient population

January 2022 60 pages

Anal Cancer - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Anal Cancer Key assessments Patient Segmentation in Anal Cancer Anal Cancer Risk & Burden Factors driving growth in a specific Anal Cancer patient population

January 2022 60 pages

Anti-hypertension - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... Pipeline Analysis Anti-hypertension Market Size and Trends Anti-hypertension Market Opportunities Impact of upcoming Therapies in Anti-hypertension Anti-hypertension Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Anti ...

January 2022 200 pages

Anti-hypertension - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Anti-hypertension Key assessments Patient Segmentation in Anti-hypertension Anti-hypertension Risk & Burden Factors driving growth in a specific Anti-hypertension patient population

January 2022 60 pages

Atopic Dermatitis (AD) - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Atopic Dermatitis (AD) Key assessments Patient Segmentation in Atopic Dermatitis (AD) Atopic Dermatitis (AD) Risk & Burden Factors driving growth in a specific Atopic Dermatitis (AD) patient population

January 2022 60 pages

Atrial Fibrillation - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Atrial Fibrillation Key assessments Patient Segmentation in Atrial Fibrillation Atrial Fibrillation Risk & Burden Factors driving growth in a specific Atrial Fibrillation patient population

January 2022 60 pages

Attention-deficit/hyperactivity disorder (ADHD) - Epidemiology Forecast to 2032

US$ 3,950.00

... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Attention-deficit/hyperactivity disorder (ADHD) Key assessments Patient Segmentation in Attention-deficit/hyperactivity disorder (ADHD) Attention-deficit/hyperactivity disorder (ADHD) Risk & Burden Factors driving growth ...

January 2022 60 pages

Benign prostatic hyperplasia (BPH) - Epidemiology Forecast to 2032

US$ 3,950.00

... Key strengths 10 Year Forecast 7MM Coverage Total Cases in Benign prostatic hyperplasia (BPH) Key assessments Patient Segmentation in Benign prostatic hyperplasia (BPH) Benign prostatic hyperplasia (BPH) Risk & Burden Factors driving growth in a specific Benign prostatic hyperplasia (BPH) patient population

January 2022 60 pages

Food Allergy - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... upcoming Therapies in Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Chronic Obstructive Pulmonary Disease (COPD) Report Assessment ...

January 2022 200 pages

Chronic Urticaria Therapeutics - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... Therapeutics Pipeline Analysis Chronic Urticaria Therapeutics Market Size and Trends Chronic Urticaria Therapeutics Market Opportunities Impact of upcoming Therapies in Chronic Urticaria Therapeutics Chronic Urticaria Therapeutics Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation ...

January 2022 200 pages

Crohn's Disease (CD) - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Crohn’s Disease (CD) Key assessments Patient Segmentation in Crohn’s Disease (CD) Crohn’s Disease (CD) Risk & Burden Factors driving growth in a specific Crohn’s Disease (CD) patient population

January 2022 60 pages

Cystic fibrosis - Epidemiology Forecast to 2032

US$ 3,950.00

... 10 Year Forecast 7MM Coverage Total Cases in Cystic fibrosis Epidemiology Forecast Key assessments Patient Segmentation in Cystic fibrosis Epidemiology Forecast Cystic fibrosis Epidemiology Forecast Risk & Burden Factors driving growth in a specific Cystic fibrosis Epidemiology Forecast patient population

January 2022 60 pages

Cytomegalovirus (CMV) Infection - Epidemiology Forecast to 2032

US$ 3,950.00

... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cytomegalovirus (CMV) Infection Key assessments Patient Segmentation in Cytomegalovirus (CMV) Infection Cytomegalovirus (CMV) Infection Risk & Burden Factors driving growth in a specific Cytomegalovirus (CMV) Infection patient ...

January 2022 60 pages

Dermatophytic Onychomycosis - Epidemiology Forecast to 2032

US$ 3,950.00

... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dermatophytic Onychomycosis Key assessments Patient Segmentation in Dermatophytic Onychomycosis Dermatophytic Onychomycosis Risk & Burden Factors driving growth in a specific Dermatophytic Onychomycosis patient population

January 2022 60 pages

Diabetic Foot Ulcers (DFUs) - Epidemiology Forecast to 2032

US$ 3,950.00

... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic foot ulcers (DFUs) Key assessments Patient Segmentation in Diabetic foot ulcers (DFUs) Diabetic foot ulcers (DFUs) Risk & Burden Factors driving growth in a specific Diabetic foot ulcers (DFUs) patient population

January 2022 60 pages

Diabetic Gastroparesis - Epidemiology Forecast-2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic Gastroparesis Key assessments Patient Segmentation in Diabetic Gastroparesis Diabetic Gastroparesis Risk & Burden Factors driving growth in a specific Diabetic Gastroparesis patient population

January 2022 60 pages

Diabetic Macular Edema (DME) - Epidemiology Forecast to 2032

US$ 3,950.00

... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic Macular Edema (DME) Key assessments Patient Segmentation in Diabetic Macular Edema (DME) Diabetic Macular Edema (DME) Risk & Burden Factors driving growth in a specific Diabetic Macular Edema (DME) patient population

January 2022 60 pages

Diabetic Nephropathy - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic Nephropathy Key assessments Patient Segmentation in Diabetic Nephropathy Diabetic Nephropathy Risk & Burden Factors driving growth in a specific Diabetic Nephropathy patient population

January 2022 60 pages

Dry eye disease - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dry eye disease Key assessments Patient Segmentation in Dry eye disease Dry eye disease Risk & Burden Factors driving growth in a specific Dry eye disease patient population

January 2022 60 pages

Duchenne Muscular Dystrophy - Epidemiology Forecast to 2032

US$ 3,950.00

... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Duchenne Muscular Dystrophy Key assessments Patient Segmentation in Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy Risk & Burden Factors driving growth in a specific Duchenne Muscular Dystrophy patient population

January 2022 60 pages

Dyslipidemia - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dyslipidemia Key assessments Patient Segmentation in Dyslipidemia Dyslipidemia Risk & Burden Factors driving growth in a specific Dyslipidemia patient population

January 2022 60 pages

Dysmenorrhea - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dysmenorrhea Key assessments Patient Segmentation in Dysmenorrhea Dysmenorrhea Risk & Burden Factors driving growth in a specific Dysmenorrhea patient population

January 2022 60 pages

Eczema - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Eczema Key assessments Patient Segmentation in Eczema Eczema Risk & Burden Factors driving growth in a specific Eczema patient population

January 2022 60 pages

Endometrial Cancer - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Endometrial Cancer Key assessments Patient Segmentation in Endometrial Cancer Endometrial Cancer Risk & Burden Factors driving growth in a specific Endometrial Cancer patient population

January 2022 60 pages

Epilepsy - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Epilepsy Key assessments Patient Segmentation in Epilepsy Epilepsy Risk & Burden Factors driving growth in a specific Epilepsy patient population

January 2022 60 pages

Ewing Sarcoma - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Ewing Sarcoma Key assessments Patient Segmentation in Ewing Sarcoma Ewing Sarcoma Risk & Burden Factors driving growth in a specific Ewing Sarcoma patient population

January 2022 60 pages

Fibromyalgia - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Fibromyalgia Key assessments Patient Segmentation in Fibromyalgia Fibromyalgia Risk & Burden Factors driving growth in a specific Fibromyalgia patient population

January 2022 60 pages

Gallbladder Cancer - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gallbladder Cancer Key assessments Patient Segmentation in Gallbladder Cancer Gallbladder Cancer Risk & Burden Factors driving growth in a specific Gallbladder Cancer patient population

January 2022 60 pages

Gastric Cancer - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gastric Cancer Key assessments Patient Segmentation in Gastric Cancer Gastric Cancer Risk & Burden Factors driving growth in a specific Gastric Cancer patient population

January 2022 60 pages

Gastroesophageal Reflux Disease (GERD) - Epidemiology Forecast to 2032

US$ 3,950.00

... Year Forecast 7MM Coverage Total Cases in Gastroesophageal Reflux Disease (GERD) Key assessments Patient Segmentation in Gastroesophageal Reflux Disease (GERD) Gastroesophageal Reflux Disease (GERD) Risk & Burden Factors driving growth in a specific Gastroesophageal Reflux Disease (GERD) patient population

January 2022 60 pages

Gaucher's disease - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gaucher’s disease Key assessments Patient Segmentation in Gaucher’s disease Gaucher’s disease Risk & Burden Factors driving growth in a specific Gaucher’s disease patient population

January 2022 60 pages

Genital Herpes - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Genital Herpes Key assessments Patient Segmentation in Genital Herpes Genital Herpes Risk & Burden Factors driving growth in a specific Genital Herpes patient population

January 2022 60 pages

Glaucoma - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Glaucoma Key assessments Patient Segmentation in Glaucoma Glaucoma Risk & Burden Factors driving growth in a specific Glaucoma patient population

January 2022 60 pages

Glioblastoma Multiforme (GBM) - Epidemiology Forecast to 2032

US$ 3,950.00

... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Glioblastoma multiforme (GBM) Key assessments Patient Segmentation in Glioblastoma multiforme (GBM) Glioblastoma multiforme (GBM) Risk & Burden Factors driving growth in a specific Glioblastoma multiforme (GBM) patient population ...

January 2022 60 pages

Glioma - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Glioma Key assessments Patient Segmentation in Glioma Glioma Risk & Burden Factors driving growth in a specific Glioma patient population

January 2022 60 pages

Graves Disease - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Graves Disease Key assessments Patient Segmentation in Graves Disease Graves Disease Risk & Burden Factors driving growth in a specific Graves Disease patient population

January 2022 60 pages

Growth Hormone Deficiency (GHD) - Epidemiology Forecast to 2032

US$ 3,950.00

... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Growth Hormone Deficiency (GHD) Key assessments Patient Segmentation in Growth Hormone Deficiency (GHD) Growth Hormone Deficiency (GHD) Risk & Burden Factors driving growth in a specific Growth Hormone Deficiency (GHD) patient ...

January 2022 60 pages

Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032

US$ 3,950.00

... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Guillain-Barre Syndrome (GBS) Key assessments Patient Segmentation in Guillain-Barre Syndrome (GBS) Guillain-Barre Syndrome (GBS) Risk & Burden Factors driving growth in a specific Guillain-Barre Syndrome (GBS) patient population ...

January 2022 60 pages

Filters

Search

Categories

5,477
618
651
143

Publishers

6,889

Regions

6,889

Price

Date

Pages

Offers